296 related articles for article (PubMed ID: 23038271)
1. 5-HT(3) receptors.
Lummis SC
J Biol Chem; 2012 Nov; 287(48):40239-45. PubMed ID: 23038271
[TBL] [Abstract][Full Text] [Related]
2. 5-HT3 receptors.
Thompson AJ; Lummis SC
Curr Pharm Des; 2006; 12(28):3615-30. PubMed ID: 17073663
[TBL] [Abstract][Full Text] [Related]
3. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.
Trattnig SM; Harpsøe K; Thygesen SB; Rahr LM; Ahring PK; Balle T; Jensen AA
J Biol Chem; 2012 Jul; 287(30):25241-54. PubMed ID: 22589534
[TBL] [Abstract][Full Text] [Related]
5. Allosteric activation of the 5-HT3AB receptor by mCPBG.
Miles TF; Lester HA; Dougherty DA
Neuropharmacology; 2015 Apr; 91():103-8. PubMed ID: 25541413
[TBL] [Abstract][Full Text] [Related]
6. 5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.
Newman AS; Batis N; Grafton G; Caputo F; Brady CA; Lambert JJ; Peters JA; Gordon J; Brain KL; Powell AD; Barnes NM
Br J Pharmacol; 2013 Jul; 169(6):1228-38. PubMed ID: 23594147
[TBL] [Abstract][Full Text] [Related]
7. Discriminating between 5-HT₃A and 5-HT₃AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Jun; 169(4):736-47. PubMed ID: 23489111
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in 5-HT3 receptor pharmacology.
Thompson AJ
Trends Pharmacol Sci; 2013 Feb; 34(2):100-9. PubMed ID: 23380247
[TBL] [Abstract][Full Text] [Related]
9. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
Lochner M; Lummis SC
Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity amongst 5-HT₃ receptor subunits: is this significant?
Yaakob N; Malone DT; Exintaris B; Irving HR
Curr Mol Med; 2011 Feb; 11(1):57-68. PubMed ID: 21189117
[TBL] [Abstract][Full Text] [Related]
11. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
12. Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.
Del Cadia M; De Rienzo F; Weston DA; Thompson AJ; Menziani MC; Lummis SC
Bioorg Med Chem; 2013 Dec; 21(23):7523-8. PubMed ID: 24128813
[TBL] [Abstract][Full Text] [Related]
13. The 5-HT3 receptor as a therapeutic target.
Thompson AJ; Lummis SC
Expert Opin Ther Targets; 2007 Apr; 11(4):527-40. PubMed ID: 17373882
[TBL] [Abstract][Full Text] [Related]
14. Visualising functional 5-HT
Abad IPL; Fam RL; Nguyen DT; Nowell CJ; Trinh PNH; Manallack DT; Freihat LA; Chakrabarti J; Jamil A; Exintaris B; Yaakob NS; Irving HR
Biomed Pharmacother; 2020 Dec; 132():110860. PubMed ID: 33059258
[TBL] [Abstract][Full Text] [Related]
15. Defining the roles of Asn-128, Glu-129 and Phe-130 in loop A of the 5-HT3 receptor.
Sullivan NL; Thompson AJ; Price KL; Lummis SC
Mol Membr Biol; 2006; 23(5):442-51. PubMed ID: 17060161
[TBL] [Abstract][Full Text] [Related]
16. The Binding of Palonosetron and Other Antiemetic Drugs to the Serotonin 5-HT3 Receptor.
Zarkadas E; Zhang H; Cai W; Effantin G; Perot J; Neyton J; Chipot C; Schoehn G; Dehez F; Nury H
Structure; 2020 Oct; 28(10):1131-1140.e4. PubMed ID: 32726573
[TBL] [Abstract][Full Text] [Related]
17. 5-HT(3) receptors: role in disease and target of drugs.
Walstab J; Rappold G; Niesler B
Pharmacol Ther; 2010 Oct; 128(1):146-69. PubMed ID: 20621123
[TBL] [Abstract][Full Text] [Related]
18. The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.
Lochner M; Thompson AJ
Neuropharmacology; 2016 Sep; 108():220-8. PubMed ID: 27108935
[TBL] [Abstract][Full Text] [Related]
19. Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.
Moura Barbosa AJ; De Rienzo F; Ramos MJ; Menziani MC
Eur J Med Chem; 2010 Nov; 45(11):4746-60. PubMed ID: 20724042
[TBL] [Abstract][Full Text] [Related]
20. Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.
Duffy NH; Lester HA; Dougherty DA
ACS Chem Biol; 2012 Oct; 7(10):1738-45. PubMed ID: 22873819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
